Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries

Author(s):  Guth Michael AS

Issue:  Sep/Oct 2015 - Volume 19, Number 5
View All Articles in Issue

Page(s):  367-373

Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries Page 1
Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries Page 2
Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries Page 3
Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries Page 4
Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries Page 5
Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries Page 6
Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries Page 7

Download in electronic PDF format for $65

Abstract:  Several studies have addressed the optimal storage conditions for vascular grafts during bypass surgery. These studies have repeatedly shown that placing vascular graft conduits in isotonic saline solutions, and to a lesser extent in heparinized autologous blood, leads to a profound decline in endothelial cell viability. Endothelial damage to vein grafts can occur at multiple points during a coronary artery bypass graft surgery procedure: graft harvesting, handling, flushing, storage, anastomosis, and arterialization (e.g., damage caused by exposure to arterial blood pressure). This damage to endothelial cells causes the release of pro-inflammatory chemical signals that trigger thrombosis, intimal hyperplasia, and accelerated graft atherosclerosis, all of which ultimately contribute to graft failure. Cardiothoracic surgeons performing coronary artery bypass graft surgery and vascular surgeons performing peripheral artery bypass graft surgery have attempted to overcome the damage to the vascular grafts by using buffers to maintain the physiological pH of the storage solution. However, the endothelial layers in the grafts would benefit from having proper oxygenation and antioxidants added to the storage solution. Compounding pharmacies can perform a vital role in ensuring the patency of the vascular grafts by creating compounded flushing and storage solutions that have an optimal mix of nitric oxide substrates, antioxidants, and other nutrients for the endothelium. Maintaining structural and functional viability of the endothelia in grafts by using an appropriate vessel storage medium would lead to improved long-term graft patency.

Related Keywords: Michael A.S. Guth, PhD, JD, coronary artery bypass graft, CABG, peripheral artery bypass graft, saphenous vein harvest, vascular graft, blood vessels, arterial blockage, cardioplegic solutions, graft flushing and storage solution, amino acids, Krebs-Henseleit buffer, Krebs-Henseleit solution, class II medical device, basal salt solutions, irrigation, transport, cellular osmotic balance, cell metabolism, formulation, preservation of endothelial cell function, cyclic guanosine monophosphate, cGMP, nitric oxide substrates, adenosine triphosphate, ATP, arginine, citrulline malate, superoxide dismutase, SOD, luteolin, ellagic acid, punicic acid, punicalagin, angiogenesis, antioxidants

Related Categories: FORMULATIONS, CARDIOLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries
Guth Michael AS
Sep/Oct 2015
Pg. 367-373

Natural Testosterone: Hormone of the Heart
Wright Jonathan V
, Lenard Lane
Mar/Apr 1999
Pg. 88-98

Adult Peripheral Parenteral Nutrition Solution with 4.23% Amino Acids
Allen Loyd V Jr
Sep/Oct 1998
Pg. 366

Adult Peripheral Parenteral Nutrition Solution with 2.5% Amino Acids
Allen Loyd V Jr
Sep/Oct 1998
Pg. 367

Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48

Formulation and Stability of Solutions
Akers Michael J
Jan/Feb 2016
Pg. 41-45

Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations
Allen Loyd V Jr
Nov/Dec 2017
Pg. 481-486

Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report
Mixon Bill
, Mixon Jan, Isbey Edward K III, Sprinkle Shari
Sep/Oct 2014
Pg. 370-377

Compounded Testosterone Troches to optimize Health and the Testosterone Controversy
Guth Michael AS
May/Jun 2015
Pg. 195-203

Utilization of Compounded Medications in an Oral Medicine Practice
Stock Shannon
, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
Mar/Apr 2016
Pg. 155-158